Delivery Order SPE2DB20D2014-SPE2DB24FC76V
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp is for the delivery of 4,566,347,690 units of the Boostrix TDAP vaccine syringe (0.5mL). The $22,644.24 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) with a completion date of November 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award is for the delivery of 4,564,857,040 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL) to the Defense Logistics Agency (DLA). The $2,783.88 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier to the U.S. government. The award has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $35,965.16 firm-fixed-price delivery order is for the supply of 4,566,106,682 units of the BOOSTRIX TDAP vaccine syringe (0.5 ml). The award is not associated with a set-aside program. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract, valued at $6,444.50, was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of Boostrix TDAP vaccine syringes in 0.5 ml doses. The contract has a ceiling value of $1,546.68 and an ultimate completion date of May 16, 2024. This order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD), under an Indefinite Delivery Contract (IDC) with Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,086,434 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $2,997.58 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 8, 2024, with a completion date of July 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,097.72 firm fixed-price delivery order is for the supply of 4,565,469,335 units of the BOOSTRIX TDAP vaccine syringe (0.5ML). This award is not associated with any set-aside designation. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the BOOSTRIX TDAP vaccine syringe 0.5mL. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a firm fixed price of $1,063.64. The contract does not have a set-aside designation, indicating it was awarded through open competition. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,098.40 firm fixed-price delivery order is for the supply of 4,561,082,760 Boostrix TDAP vaccine syringes, with a performance period through May 31, 2023. The award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,427.58, is for the delivery of 4,567,957,139 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 18, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp...